Systemic sclerosis
Publication date
2018-06-19
Editors
Advisors
Supervisors
Document Type
Part of book
Metadata
Show full item recordCollections
License
taverne
Abstract
Systemic sclerosis (SSc) is a rare systemic autoimmune connective tissue disease with clinical and laboratory features of inflammation, vasculopathy, and fibrosis of the skin and visceral organs. The role of the microbiota is an area that is largely unexplored in SSc. An overview is given of the studies that investigated the composition of the microbiome in the gastrointestinal tract and the skin. Furthermore, hypotheses that may strengthen the rationale for further investigation of the microbiome in SSc are discussed. There is tentative evidence that alterations in the microbiome can be associated with SSc. However, more research is needed to establish if these altered populations are the cause or the result of the disease. The fact that SSc affects the skin, lungs, and gastrointestinal tract, which are prominent locations of the microbiome, makes it both more challenging and interesting to explore the role of microorganisms in the disease process.
Keywords
Taverne, General Medicine
Citation
Spierings, J, van Rhijn-Brouwer, F C & van Laar, J M 2018, Systemic sclerosis. in The Microbiome in Rheumatic Diseases and Infection. Springer, pp. 337-346. https://doi.org/10.1007/978-3-319-79026-8_24